| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/18/2013 | US20130096177 Polymers for delivering molecules of interest |
| 04/18/2013 | US20130096096 Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| 04/18/2013 | US20130096069 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 04/18/2013 | US20130096049 Therapeutic conjugates |
| 04/18/2013 | US20130095191 Passive Methods for Anti-Microbial Biologic Meshes |
| 04/18/2013 | US20130095166 Adhesive composition for medical use, patch for medical use, and method for producing the composition |
| 04/18/2013 | US20130095163 Foaming formulations and cleansing products including silicone polyesters |
| 04/18/2013 | US20130095156 Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents |
| 04/18/2013 | US20130095153 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
| 04/18/2013 | US20130095147 Sol-gel derived bioactive glass polymer composite |
| 04/18/2013 | US20130095146 Ciclesonide containing aqueous pharmaceutical composition |
| 04/18/2013 | US20130095124 Compositions for transfection of biomolecules into cells |
| 04/18/2013 | US20130095123 New binder-drug conjugates (ADCs) and use thereof |
| 04/18/2013 | US20130095111 Fusion proteins in cancer |
| 04/18/2013 | US20130095087 Absorbable in situ gel-forming system, method of making and use thereof |
| 04/18/2013 | US20130095071 Method of treating or preventing hearing loss |
| 04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | DE19780440B3 Insektizidkombination gegen Läuse von Säugern, insbesondere von Hunden und Katzen Insecticide combination against lice of mammals, especially dogs and cats |
| 04/18/2013 | CA2852099A1 Meditopes and meditope-binding antibodies and uses thereof |
| 04/18/2013 | CA2852068A1 In situ forming hydrogel and method using same |
| 04/18/2013 | CA2852064A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 04/18/2013 | CA2852058A1 Solid dispersion |
| 04/18/2013 | CA2851667A1 Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| 04/18/2013 | CA2851588A1 Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy)-1h-quinolin-2-one or a salt thereof |
| 04/18/2013 | CA2851371A1 Zymogen activators |
| 04/18/2013 | CA2850373A1 Pyrrolobenzodiazepines and targeted conjugates |
| 04/18/2013 | CA2850371A1 Pyrrolobenzodiazepines and conjugates thereof |
| 04/18/2013 | CA2850145A1 Methods |
| 04/18/2013 | CA2849538A1 Porphyrin microbubbles |
| 04/18/2013 | CA2849192A1 Prevention and treatment of ocular conditions |
| 04/17/2013 | EP2581444A2 Deacetylation hydrolase of hyaluronic acid, hyaluronic acid deacetylated by same and derivative thereof |
| 04/17/2013 | EP2581085A1 Pharmaceutical composition for nasal administration of metopimazine |
| 04/17/2013 | EP2581084A1 Solid dispersion comprising triazole compound |
| 04/17/2013 | EP2581079A1 Combination of hyaluronic acid and prilocaine |
| 04/17/2013 | EP2581078A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 04/17/2013 | EP2580248A1 An enzymatic method of producing a hydrogel from xylan |
| 04/17/2013 | EP2579899A2 Cell-penetrating peptides and uses thereof |
| 04/17/2013 | EP2579898A1 Peptide-carrying nanoparticles |
| 04/17/2013 | EP2579897A1 Cysteine engineered antibodies and conjugates |
| 04/17/2013 | EP2579896A1 Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| 04/17/2013 | EP2579889A2 Fgf21 analogues and derivatives |
| 04/17/2013 | EP2579875A2 Compositions comprising buprenorphine |
| 04/17/2013 | EP2579874A2 Injectable flowable composition comprising buprenorphine |
| 04/17/2013 | EP2579869A2 Formulations including amiodarone and salts thereof and methods of their manufacture and use |
| 04/17/2013 | EP2579864A1 Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients |
| 04/17/2013 | EP2579856A1 An injectable dosage form of flupirtine |
| 04/17/2013 | EP2579852A1 A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid |
| 04/17/2013 | EP2579850A1 Novel process |
| 04/17/2013 | EP2579847A1 Antimycotic pharmaceutical composition |
| 04/17/2013 | EP2579845A1 Ophthalmic compositions for the administration of liposoluble acitve ingredients |
| 04/17/2013 | EP2579844A1 Nanoparticle film delivery systems |
| 04/17/2013 | EP2494956A9 Paclitaxel/steroidal complex |
| 04/17/2013 | EP2014304B9 Colon cleansing compositions |
| 04/17/2013 | EP1600141B1 Collagenolytic active enzyme containing compositions for the treatment of dental caries |
| 04/17/2013 | CN1604788B High-concentration protein formulations and method of manufacture |
| 04/17/2013 | CN103052405A Oligonucleotide Chelate Complexes |
| 04/17/2013 | CN103052398A Stabilization of fsh |
| 04/17/2013 | CN103052386A Composition containing tetracyclic compound |
| 04/17/2013 | CN103052385A Methods of treatment of hepatocellular carcinoma |
| 04/17/2013 | CN103052382A Solid dispersion of alfa-ketoamide derivatives |
| 04/17/2013 | CN103046158A Spinning solution, nuclear shell nanofiber as well as preparation method and application thereof |
| 04/17/2013 | CN103045601A Improved modulators of coagulation factors |
| 04/17/2013 | CN103045576A PolyHb-rPA complex, preparation method and application of PolyHb-rPA complex |
| 04/17/2013 | CN103044688A Preparation method of thermo-sensitive graphene oxide with improved replacement rate by triggering polymerization through advanced modification |
| 04/17/2013 | CN103044686A Preparation and application of mixed structure PLGA-PLL-PEG targeting polymer carrier |
| 04/17/2013 | CN103044676A Polyethyleneglycol modified biologically-relevant substance |
| 04/17/2013 | CN103044675A Monofunctional branched polyethyleneglycol |
| 04/17/2013 | CN103044556A Recombined fusion protein VIP-TAT and application thereof |
| 04/17/2013 | CN103044555A Fused protein containing cFms extracellular fragments, preparation method and applications of fused protein with cFms extracellular fragments |
| 04/17/2013 | CN103044552A Humanized monoclonal antibody for resisting DEC-205 molecules on surface of dendritic cells |
| 04/17/2013 | CN103044550A IL-31 monoclonal antibodies and methods of use |
| 04/17/2013 | CN103044539A Reorganizational hemopoietin and preparation method thereof |
| 04/17/2013 | CN103044523A Dexamethasone-RGD polypeptide conjugate, preparation method thereof and application |
| 04/17/2013 | CN103044521A Aspartase-targeted activated adriamycin derivative as well as preparation method and application thereof |
| 04/17/2013 | CN103044459A Novel cefmetazole compound and medicine composition thereof |
| 04/17/2013 | CN103043724A Oxidized graphene/MnFe2O4 nanometer hybrid material and preparation method thereof |
| 04/17/2013 | CN103041448A Compound polysaccharide hemostatic material and preparation method and application thereof |
| 04/17/2013 | CN103041409A Preparation method of pH and thermal dual-sensitive lipidosome loaded with magnetic carbon quantum dots on internal water phase |
| 04/17/2013 | CN103041406A Method for preparing diagnosis and treatment-cooperated nano particles release system by template method |
| 04/17/2013 | CN103041405A Diagnosis-treatment integrative medicine carrying polymer and preparation method thereof |
| 04/17/2013 | CN103041403A Glucan-containing pharmaceutical composition and preparation method thereof |
| 04/17/2013 | CN103041402A Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation |
| 04/17/2013 | CN103041401A Targeted anti-bladder-cancer albumin carrying mitomycin drug and preparation method thereof |
| 04/17/2013 | CN103041400A Preparation method of antimicrobial peptide loaded chitosan/gamma polyglutamic acid composite nanoparticles |
| 04/17/2013 | CN103041399A Heat-resisting protective agent and application thereof |
| 04/17/2013 | CN103041398A Film-coated agent for improving coating film mouthfeel of food and drug and preparation method thereof |
| 04/17/2013 | CN103041397A Sodium alga acid capsule and production process thereof |
| 04/17/2013 | CN103041396A Enteric polyacrylic resin medicament film coating aqueous dispersion and preparation method thereof |
| 04/17/2013 | CN103041395A Osmotic slow-release material in ethyl acrylate-methyl methacrylate copolymer aqueous dispersion and preparation method thereof |
| 04/17/2013 | CN103041394A Waterborne enteric-solubility polyacrylic resin drug coating and preparation method thereof |
| 04/17/2013 | CN103041393A Preparation method of nano multi-medicine medicine carrying system for treating cancer |
| 04/17/2013 | CN103041383A Heatproof freeze-drying protective agent of live vaccine, live vaccine freeze-drying powder and preparation method and preparation method of live vaccine freeze-drying powder |
| 04/17/2013 | CN103041380A Stabilizer in dry heat treatment process of human antithrombase preparation |
| 04/17/2013 | CN103041377A Preparation method of lysozyme loaded chitosan/gamma polyglutamic acid composite nanoparticles |
| 04/17/2013 | CN103041370A Drug composition containing recombinant human erythropoietin and preparation method of drug composition |
| 04/17/2013 | CN103041322A Pinellia ternate heart-fire removing dropping pill and preparation method thereof |
| 04/17/2013 | CN103041311A Baofukang suppository with expansion carrier |
| 04/17/2013 | CN103041296A Traditional Chinese medicine solid granule capsules containing curcuma zedoary volatile oil and Wuling mycelia powder and preparation method thereof |
| 04/17/2013 | CN103041055A Hypoglycemic dispersible tablet and processing technology thereof |